Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia
Titel:
Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia
Auteur:
Jabbour, Elias DerSarkissian, Maral Duh, Mei Sheng McCormick, Nora Cheng, Wendy Y. McGarry, Lisa J. Souroutzidis, Ariadne Huang, Hui O’Brien, Susan Ravandi, Farhad Kantarjian, Hagop M.